X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2719) 2719
Publication (352) 352
Book Review (16) 16
Book Chapter (12) 12
Conference Proceeding (3) 3
Dissertation (3) 3
Magazine Article (3) 3
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1514) 1514
animals (1297) 1297
male (1291) 1291
index medicus (1252) 1252
quinoxalines - therapeutic use (1230) 1230
quinoxalines - pharmacology (1110) 1110
female (870) 870
pharmacology & pharmacy (791) 791
varenicline (648) 648
rats (628) 628
benzazepines - therapeutic use (516) 516
middle aged (512) 512
adult (473) 473
mice (419) 419
quinoxalines - administration & dosage (415) 415
brimonidine tartrate (400) 400
smoking cessation - methods (397) 397
dose-response relationship, drug (378) 378
neurosciences (378) 378
nicotinic agonists - therapeutic use (360) 360
quinoxalines - adverse effects (354) 354
treatment outcome (340) 340
aged (337) 337
smoking cessation (279) 279
rats, sprague-dawley (242) 242
quinoxalines - chemistry (238) 238
receptor partial agonist (228) 228
oxadiazoles - pharmacology (208) 208
psychiatry (200) 200
analysis (193) 193
benzazepines - adverse effects (193) 193
ophthalmology (192) 192
bupropion - therapeutic use (190) 190
excitatory amino acid antagonists - pharmacology (190) 190
sustained-release bupropion (189) 189
time factors (186) 186
double-blind method (184) 184
in vitro techniques (182) 182
article (179) 179
efficacy (179) 179
intraocular pressure - drug effects (178) 178
chemistry, medicinal (174) 174
drug therapy, combination (174) 174
rats, wistar (174) 174
smoking (163) 163
enzyme inhibitors - pharmacology (158) 158
biochemistry & molecular biology (151) 151
research (151) 151
nicotine (147) 147
smoking cessation programs (146) 146
glaucoma (145) 145
disease models, animal (144) 144
nitric oxide (144) 144
brimonidine (143) 143
adolescent (137) 137
smoking-cessation (137) 137
quinoxalines - chemical synthesis (136) 136
young adult (132) 132
care and treatment (131) 131
nicotinic agonists - adverse effects (131) 131
receptors, ampa - antagonists & inhibitors (129) 129
tobacco use disorder - drug therapy (129) 129
medicine, general & internal (127) 127
glutamate (126) 126
in-vitro (126) 126
pharmacology/toxicology (126) 126
antihypertensive agents - therapeutic use (125) 125
drug therapy (125) 125
quinoxaline (125) 125
adrenergic alpha-agonists - therapeutic use (124) 124
cancer (123) 123
safety (123) 123
quinoxalines - pharmacokinetics (119) 119
aged, 80 and over (118) 118
apoptosis (118) 118
therapy (117) 117
structure-activity relationship (115) 115
glaucoma, open-angle - drug therapy (114) 114
quinoxalines (113) 113
benzazepines - administration & dosage (112) 112
benzazepines - pharmacology (109) 109
ocular hypertension - drug therapy (109) 109
cell line, tumor (108) 108
oncology (108) 108
placebo (108) 108
drug combinations (107) 107
prospective studies (106) 106
randomized controlled-trial (106) 106
pharmacology (105) 105
rat (105) 105
receptors, n-methyl-d-aspartate - antagonists & inhibitors (104) 104
pharmacotherapy (103) 103
smoking - drug therapy (103) 103
cells, cultured (101) 101
guanylate cyclase - antagonists & inhibitors (100) 100
abridged index medicus (99) 99
activation (99) 99
molecular structure (99) 99
health aspects (98) 98
sulfonamides - therapeutic use (98) 98
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2573) 2573
Russian (60) 60
German (28) 28
French (27) 27
Japanese (22) 22
Spanish (14) 14
Chinese (6) 6
Romanian (5) 5
Czech (4) 4
Polish (4) 4
Dutch (3) 3
Italian (2) 2
Swedish (2) 2
Danish (1) 1
Hungarian (1) 1
Korean (1) 1
Portuguese (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2016, Volume 2016, Issue 5, p. CD006103
Background Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract... 
Smoking [drug therapy] | Varenicline | Humans | RANDOMIZED CONTROLLED-TRIAL | Quinolizines [therapeutic use] | PSYCHIATRIC ADVERSE EVENTS | TOBACCO-DEPENDENCE TREATMENT | Quinoxalines [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Bupropion [therapeutic use] | Nicotine [adverse effects; antagonists & inhibitors] | REPLACEMENT THERAPY | SUSTAINED-RELEASE BUPROPION | Smoking Cessation [methods] | Counseling [methods] | VARENICLINE TREATMENT | METHADONE-MAINTAINED SMOKERS | Randomized Controlled Trials as Topic | Azepines [therapeutic use] | DOUBLE-BLIND PLACEBO | Alkaloids [therapeutic use] | Nicotinic Agonists [adverse effects; therapeutic use] | Azocines [therapeutic use] | LONG-TERM SAFETY | Benzazepines [therapeutic use] | PLACEBO-CONTROLLED TRIAL | Substance Withdrawal Syndrome [prevention & control] | Heterocyclic Compounds with 4 or More Rings [therapeutic use] | Quinolizines - therapeutic use | Azepines - adverse effects | Azocines - therapeutic use | Azocines - adverse effects | Substance Withdrawal Syndrome - prevention & control | Alkaloids - adverse effects | Benzazepines - adverse effects | Smoking - drug therapy | Heterocyclic Compounds, 4 or More Rings - adverse effects | Nicotinic Agonists - therapeutic use | Nicotine - antagonists & inhibitors | Smoking Cessation - methods | Azepines - therapeutic use | Nicotine - adverse effects | Nicotinic Agonists - adverse effects | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Benzazepines - therapeutic use | Counseling - methods | Alkaloids - therapeutic use | Quinolizines - adverse effects | Varenicline - therapeutic use | Bupropion - therapeutic use
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 4, Issue 4, p. CD006103
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2015, Volume 4, Issue 5, p. CD003262
Journal Article
Liver International, ISSN 1478-3223, 01/2016, Volume 36, Issue S1, pp. 47 - 57
Journal Article
Journal Article
Journal Article